GL1X · GenesisL1 explorer

MolNFT v1 · #30492 · protein

Human CDK2 in complex with olomoucine II, a novel 2,6,9- trisubstituted purine cyclin-dependent kinase inhibitor

2A0C · Cell division protein kinase 2: “Human CDK2 in complex with olomoucine II, a novel 2,6,9- trisubstituted purine cyclin-dependent kinase…”. X-ray diffraction, 1 ligand (CK9), 4 pockets (best druggability 0.70). MolNFT v1 #30492 on…

PDB
2A0C
Type
protein
Length
294 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cell division protein kinase 2
EC
2.7.1.37
UniProt
P24941
Ligands
CK9
Pockets
4 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
XCell division protein kinase 2 (EC 2.7.1.37)protein29434% helix, 17% strandP24941

Ligands and binding sites

  • CK9 · 2-{[(2-{[(1R)-1-(hydroxymethyl)propyl]amino}-9-isopropyl-9H-purin-6-yl)amino]methyl}phenol · ligand · chains X

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13200.700.8436CK9
2720.370.7721empty
3720.360.7618empty
4520.250.7316empty

Compared structures

  • 2A0C · Human CDK2 in complex with olomoucine II, a novel 2,6,9-trisubstituted purine… · the same entry in another collection · chain X against X, TM-score 1.00
  • P24941 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 2 (P24941) · a predicted model of the same protein · chain X against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.